source
- Innovent Biologics partners with Spero to advance autoimmune drug candidate beyond GSK antibioticInnovent Biologics has announced a new partnership with Spero, a smaller biopharma firm, to develop an autoimmune drug candidate originating from Suzhou, China. The collaboration follows a series…
- Experts say MDUFA VI draft letter improves program while addressing FDA resource limitsIndustry experts note that the draft commitment letter for the upcoming Medical Device User Fee Amendments (MDUFA VI) offers enhancements over the current framework and takes into account the FDA’s…